Variant report
Variant | esv3414306 |
---|---|
Chromosome Location | chr16:59303551-59308549 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190299666 | chr16:59303569-59303570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538637680 | chr16:59303610-59303611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145940247 | chr16:59303666-59303667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528794314 | chr16:59303786-59303787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10492912 | chr16:59303795-59303796 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs565283096 | chr16:59303800-59303801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139487278 | chr16:59303820-59303821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576685356 | chr16:59303857-59303858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554711998 | chr16:59303919-59303920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541777445 | chr16:59303963-59303964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536002912 | chr16:59307606-59307607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141165696 | chr16:59307626-59307627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529823460 | chr16:59307630-59307631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575979318 | chr16:59307759-59307760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546233646 | chr16:59307805-59307806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186375882 | chr16:59307809-59307810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573166878 | chr16:59307889-59307890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548158188 | chr16:59307900-59307901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540415512 | chr16:59307910-59307911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369764439 | chr16:59307967-59307968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566390705 | chr16:59307989-59307990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562200535 | chr16:59307999-59308000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529083777 | chr16:59308010-59308011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368887565 | chr16:59308018-59308019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190840694 | chr16:59308028-59308029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73553978 | chr16:59308031-59308032 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs533093593 | chr16:59308056-59308057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150737508 | chr16:59308095-59308096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139100714 | chr16:59308124-59308125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144780913 | chr16:59308131-59308132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548814596 | chr16:59308161-59308162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567307471 | chr16:59308237-59308238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535690537 | chr16:59308255-59308256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs8054778 | chr16:59308262-59308263 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs8056691 | chr16:59308284-59308285 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs537119781 | chr16:59308308-59308309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs147931460 | chr16:59308314-59308315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113269617 | chr16:59308322-59308323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371587769 | chr16:59308326-59308327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140134785 | chr16:59308328-59308329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376144941 | chr16:59308484-59308485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562065747 | chr16:59308491-59308492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78054053 | chr16:59308492-59308493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs8061349 | chr16:59308512-59308513 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs369510588 | chr16:59308514-59308515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs8061364 | chr16:59308536-59308537 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs551303440 | chr16:59308543-59308544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Infertility | 21528002 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 20409316 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Leiomyosarcoma | 16982739 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 20972252 | CNVD |
Invasive breast cancer | 20972252 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:59301600-59303600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr16:59302400-59303600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr16:59303200-59303600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr16:59303400-59303600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr16:59303400-59303800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr16:59303600-59304000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr16:59307600-59308800 | Enhancers | Fetal Heart | heart |
8 | chr16:59308000-59308200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr16:59308000-59308400 | Enhancers | Left Ventricle | heart |
10 | chr16:59308400-59309600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |